To verify the safety and potential effect on ALS progression of a low-intensity immunosuppressive regimen followed by autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis patients.
[Journal of Neurology]
Home Newsletters Hematopoiesis News A Phase I/IIa Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation in...
